Drugs / BNO 1030
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT04537819 | Mar 2019 → Jan 2020 | acute tonsillitis | Ivano-Frankivsk National Medical University | Completed | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04797936 Comparator | May → Dec 2020 | COVID-19, anosmia, nasal cavity disorder, nasopharyngitis | Ivano-Frankivsk National Medical University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BNO 1030 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04797936 ↗ |
| Known as | Imupret | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04537819 ↗ |
| Route | Oral | “Imupret oral drops” NCT04537819 ↗ |